Allspring Global Investments
EVH icon

Allspring Global Investments’s Evolent Health EVH Stock Holding History

Allspring Global Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-675
Closed -$12.9K – 2502
2024
Q2 		$12.9K Buy
+675
New +$17.2K ﹤0.01% 2180
2023
Q4 		– Sell
-3,350
Closed -$91.2K – 2390
2023
Q3 		$91.2K Sell
3,350
-415,115
-99% -$11.5M ﹤0.01% 2033
2023
Q2 		$12.7M Buy
418,465
+29,161
+7% +$943K 0.02% 726
2023
Q1 		$12.6M Buy
389,304
+52,169
+15% +$1.65M 0.02% 721
2022
Q4 		$9.47M Sell
337,135
-40,023
-11% -$1.15M 0.02% 800
2022
Q3 		$13.6M Buy
377,158
+371,140
+6,167% +$13.1M 0.02% 676
2022
Q2 		$184K Sell
6,018
-43,380
-88% -$1.26M ﹤0.01% 1838
2022
Q1 		$1.59M Buy
49,398
+2,413
+5% +$63.2K ﹤0.01% 1624
2021
Q4 		$1.3M Buy
+46,985
New +$1.35M ﹤0.01% 1777

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Allspring Global Investments's EVH Position: Q3 2024 in Review

Allspring Global Investments sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 675 shares — an estimated $12.9K sold.

Allspring Global Investments first reported a position in EVH in Q4 2021 and held it in 9 quarters. The position peaked at $13.6M in Q3 2022. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Allspring Global Investments reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 675 Evolent Health shares in Q3 2024, an estimated $12.9K.
  • Allspring Global Investments first reported a position in Evolent Health in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Evolent Health position peaked at $13.6M in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.